Study of the Therapeutic Use of Language in Patients With Metastatic Colorectal Cancer
The purpose of this study is to determine if the degree of agreement between patients and their physicians regarding the "story" of the illness correlates with improved patient symptom control and quality of life. Another goal of the study is to examine the actual language used by patients and physicians in a specific clinical situation.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Critical Negotiations: Narrative Agreement, Negotiation, and Register Use in Encounters Between Patients With Metastatic Colorectal Carcinoma and Their Oncologists|
- Correlation of degree of "narrative agreement" with validated quality of life measures [ Time Frame: 6-8 weeks ] [ Designated as safety issue: No ]
|Study Start Date:||July 2008|
|Study Completion Date:||October 2009|
|Primary Completion Date:||October 2009 (Final data collection date for primary outcome measure)|
Medical Oncologists treating patients with metastatic colorectal cancer
Patients with metastatic colorectal cancer receiving re-staging CT scans
The purpose of this study is to investigate the co-created therapeutic narrative in scheduled office visits between adult patients with metastatic colorectal carcinoma and their medical oncologists in a community practice setting. The study will focus on the negotiation of the illness narrative and the semiotic (primarily linguistic) tools employed. The study will involve patients from a large community cancer center from Northeastern Pennsylvania (this center sees about 3,000 new patients each year). About 85% of patients with cancer in the United States are treated in this type of setting (National Cancer Institute, 2007), and so many results from this population are applicable to most cancer patients in the United States. The location of this study makes it very different from the majority of medical anthropological studies that are usually performed in urban academic medical centers or in sites outside of the United States or Western Europe. Although community cancer centers are the location of most of the treatment of patients with cancer in the United States, there are few to no studies published studying this patient population.
|United States, Pennsylvania|
|Hematology and Oncology Associates of Northeastern Pennsylvania, PC|
|Dunmore, Pennsylvania, United States, 18512|
|Principal Investigator:||Christian S Adonizio, MD||Hematology and Oncology Associates of NE Pennsylvania|